Were global leaders in NAD+ research With 70,000+ NAD+ users supported and multiple peer-reviewed clinical trials, our in-house Stanford PhD-led Research Team is setting the benchmark for research-driven, clinician-guided NAD+ protocols
Trustpilot reviews lean favorable, and, importantly, the clinics responses to feedback come off as warm and individualized rather than copy-pasted script
Publishing their results in The Lancet in December 1987, the investigators concluded 'Further studies in the insulinotropic action of GLP-1 7-36 in health and disease will be of great interest
Back Klausen, MK, Jensen, ME, Mller, M, et al (6 Sept 2022) 'Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial', JCI Insight, 7/19, e159863